Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from biotechnology

3 Biotech Stocks with Promising Pipelines to Watch

As breakthroughs in biotechnology accelerate, the sector is primed for significant expansion. With emerging trends like gene editing and precision medicine transforming healthcare, fundamentally solid biotech stocks such as Amgen (AMGN), Gilead Sciences (GILD), and Biogen (BIIB) are gaining traction. With promising innovations, these stocks could be prime investment opportunities.…

StockNews.com

3 Biotech ETFs for Diversified Innovation Exposure

Biotech ETFs provide the perfect balance of high-growth potential and diversified risk, offering investors access to healthcare breakthroughs. Given this backdrop, you might consider three biotech ETFs: iShares Biotechnology ETF (IBB), SPDR S&P Biotech ETF (XBI), and First Trust NYSE Arca Biotechnology Index Fund (FBT). Keep reading….

StockNews.com

Cassava Sciences Halts Alzheimer's Drug Trials After Phase 3 Results

Cassava Sciences, Inc. (NASDAQ:SAVA, "Cassava", the "Company"))), a clinical-stage biotechnology company focused on developing a novel, investigational treatment for Alzheimer's disease (AD) dementia, today announced

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

3 Biotechnology Stocks With Promising Pipelines

With increasing chronic diseases, demand for personalized medicines, and adoption of AI, the biotech market is booming. Therefore, it could be wise to invest in solid biotech stocks Amgen (AMGN), Regeneron Pharmaceuticals (REGN), and Gilead Sciences (GILD) for substantial returns. Read more.

StockNews.com

3 Healthcare ETFs to Buy for Defensive Growth

Healthcare ETFs are an ideal investment choice for investors as they provide favorable returns, diversification, and robust growth opportunities even during economic downturns. Therefore, it could be wise to consider robust healthcare ETFs like iShares Biotechnology ETF (IBB), Vanguard Health Care Index Fund ETF Shares (VHT), and The Health Care…

StockNews.com

A giant biotechnology company might be about to go bust. What will happen to the millions of people’s DNA it holds?

Since it was founded nearly two decades ago, 23andMe has grown into one of the largest biotechnology companies in the world. Millions of people have used its simple genetic testing service, which involves ordering a saliva test, spitting into a tube, and sending it back to the company for a…

The Conversation

3 Biotech Stocks Set to Revolutionize Medicine

The biotechnology industry is rapidly evolving, with innovative companies pushing the boundaries of science and medicine. To capitalize on the industry’s expansion, it could be wise to invest in fundamentally sound biotech stocks, Gilead Sciences (GILD), Regeneron Pharmaceuticals (REGN), and Biogen (BIIB), which have the potential to revolutionize medicine. Read…

StockNews.com

Read news from The Economist, FT, and more,
with one subscription

3 Pharmaceutical Stocks That Could Lead the Next Drug Revolution

The pharmaceutical industry is promising due to AI and biotech innovations enhancing productivity, steady profits amidst economic shifts, rising chronic illnesses, and strong growth projections in global revenues and biotechnology markets. Therefore, it could be wise to invest in pharma stocks such as AbbVie (ABBV), Bristol-Myers Squibb (BMY), and Gilead…

StockNews.com

3 Biotech Stocks to Watch as FDA Approvals Roll In

The biotech sector is booming, fueled by rising healthcare demands, exciting advancements in technology, and increased FDA drug approvals. Thus, investing in Illumina (ILMN), Alnylam Pharmaceuticals (ALNY), and Gilead Sciences (GILD) could be a golden opportunity for those looking to ride the wave of future breakthroughs. Read on….

StockNews.com

Congress targets Chinese influence in health tech. It could come with tradeoffs

A San Jose-based biotechnology company that helps doctors detect genetic causes for cancer is among those that could be cut out of the U.S. market over ties to China

The Independent UK

Aging is the inflation of life. An emerging crop of longevity biotech companies needs investment to beat it

A new generation of longevity biotech companies with a more conservative approach than their predecessors has emerged—but investment remains constrained.

Fortune

London Design Festival announces the recipients of the 2024 London Design Medals

This year’s London Design Medals have been awarded to Pat McGrath DBE, Natsai Audrey Chieza, Harry Blakiston Houston and Rei Kawakubo

Wallpaper

3 High-Potential Biotech Stocks Under $10

The biotech industry is witnessing rapid growth owing to its increasing demand and the inclusion of technological advancements. In this wake, investors could consider adding pocket-friendly biotech stocks Fulcrum Therapeutics (FULC), BioCryst Pharmaceuticals (BCRX), and Precision BioSciences (DTIL) to their portfolio. Continue to read….

StockNews.com

3 Biotech ETFs for a Diversified Portfolio

The biotech industry is growing rapidly with solid advancements, and ETFs in this sector can offer great investment opportunities. Thus, it could be wise to invest in top biotech ETFs SPDR S&P Biotech ETF (XBI), VanEck Biotech ETF (BBH), and iShares Biotechnology ETF (IBB) for a diversified portfolio. Read on.

StockNews.com

Get all your
news in one place.

100's of premium titles.
One news app.

StockNews.com

3 Biotech Stocks With Anticipated Strong Earnings Reports

With highly effective drugs and treatment options, chronic disease prevalence, and adoption of technology, the biotech market is thriving. Hence, fundamentally solid biotech stocks Illumina (ILMN), Amgen (AMGN), and Entrada Therapeutics (TRDA) could be ideal with anticipated strong earnings reports. Read more.

StockNews.com

3 High-Risk, High-Reward Biotech Stocks

With ever-expanding operations, rapid technological innovation, and adoption of AI, the biotechnology industry is poised for solid long-term growth. Thus, investors could consider buying high risk, but rewarding biotech stocks United Therapeutics (UTHR), Entrada Therapeutics (TRDA), and Exelixis (EXEL). Continue reading.

The Conversation

The long – and strange – history of testing menstrual blood for health conditions

There’s good news for anyone who menstruates and doesn’t like the needles involved in blood testing. In January 2024, the biotechnology research company Qvin won FDA approval for their Q-Pad product – a menstrual pad with a removable strip to collect blood samples for clinical tests. It offers a needle-free…

Barchart

Chart of the Day: Dyne Therapeutics - Deeply Discounted

The Chart of the Day belongs to the biotechnology company Dyne Therapeutics (DYN) . I found the stock by using Barchart's powerful screening functions to find stocks with the highest technical buy signals, highest Weighted Alpha, superior current momentum and having a Trend Seeker buy signal then used the Flipchart...

Get all your
news in one place.

100's of premium titles.
One news app.

Fortune

Why places like Birmingham, Alabama are key to securing U.S. biotech dominance as China tries to close the gap

If America has any hope of maintaining its leadership in biotechnology, we must invest in places like Alabama.

International Business Times

Dr. Ashkan Afshin Is Steadily Unlocking The Potential Of Biotechnology To Revolutionize Healthcare

Dr. Afshin's early career was marked by his work at the Institute for Health Metrics and Evaluation (IHME) at the University of Washington, an institute funded by the Gates Foundation.

Dynamite News

India, US to initiate new cooperation in quantum tech, biomanufacturing; announce collaboration on telecommunication

India and the US have agreed to initiate new cooperation in the field of quantum science and technology and also develop a joint strategic framework for building biopharmaceutical supply chain optimization. Read further on Dynamite News:

Barchart

How Is Regeneron Pharmaceuticals' Stock Performance Compared to Other Biotechnology Stocks?

Regeneron Pharmaceuticals has outperformed the broader market over the past year, and Wall Street analysts are optimistic about the stock’s outlook.

Barchart

3 Cathie Wood Biotech Stocks That Analysts Expect to Double

This article delves into three biotech stocks held in Cathie Wood's ARKK ETF that analysts expect to double in value. Investors looking to add exposure to promising biotech opportunities, with a preference for Wood's disruptive approach to investing, may find these stocks particularly compelling.

StockNews.com

3 Biotech Stocks Under $20 Worth Watching in June

The biotech industry’s long-term expansion is fueled by increasing medical needs globally, favorable government support, and technological advances. Given the industry’s rosy outlook, quality biotech stocks Equillium (EQ), SIGA Technologies (SIGA), and Shionogi & Co. (SGIOY) trading under $20 could be worth watching in June. Keep reading….

StockNews.com

3 Value Biotech Stocks With Breakout Potential in 2024

Given growing healthcare spending, supportive government policies, and technological innovation, the biotechnology industry is poised for solid long-term growth. Thus, investors could consider buying quality biotech stocks Harmony Biosciences (HRMY), Esperion Therapeutics (ESPR), and Entrada Therapeutics (TRDA), which are trading at a discount. Read on….

1 … 4 5 6 7

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.